Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Med Virol ; 83(7): 1269-74, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21567429

RESUMO

A high human T-cell lymphotropic virus type 1 (HTLV-1) proviral load is described in HTLV-1-associated diseases, especially HAM/TSP. However, the cut-off value to define high levels of HTLV-1 proviral load is not well established. 281 HTLV-1-infected patients from the HTLV reference center in Salvador, Brazil, were followed from 2005 to 2008. Patients were classified as asymptomatic, possible-, probable-, and definite-HAM/TSP, in accordance with diagnostic criteria proposed by De Castro-Costa et al. (2006): AIDS Res Hum Retroviruses 22:931-935. HTLV-1 proviral load was determined using real-time PCR. A receiver operator characteristic (ROC) curve was constructed using only asymptomatic individuals and definite-HAM/TSP patients. The ROC curve was used to predict the proviral load level that differentiates these two groups. Out of 281 patients, 189 were asymptomatic and 92 were diagnosed with HAM/TSP (22 possible, 23 probable, 47 definite). The mean HTLV-1 proviral load was higher in possible- (89,104 ± 93,006 copies/106 PBMC), -probable (175,854 ± 128,083 copies/106 PBMC), and definite-HAM/TSP patients (150,667 ± 122,320 copies/106 PBMC),when compared to asymptomatic individuals (27,178 ± 41,155 copies/106 PBMC) (P < 0.0001). A comparison of all HAM/TSP groups showed the highest proviral loads in probable-HAM/TSP patients, yet the differences in mean values were not statistically significant. The ROC curve suggested a value of 49,865 copies/106 PBMC, with 87% sensitivity (95% CI » 74-95) and 81% specificity (95% CI » 75-86), as the best proviral load cut-off point to differentiate definite HAM/TSP patients from asymptomatic individuals. HTLV-1 proviral loads are higher in groups of infected patients with eurological symptoms and may represent a relevant biological marker of disease progression.


Assuntos
Infecções por HTLV-I/diagnóstico , Infecções por HTLV-I/virologia , Vírus Linfotrópico T Tipo 1 Humano/crescimento & desenvolvimento , Paraparesia Espástica Tropical/diagnóstico , Paraparesia Espástica Tropical/virologia , Provírus/crescimento & desenvolvimento , Doenças da Medula Espinal/diagnóstico , Doenças da Medula Espinal/virologia , Carga Viral , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças Assintomáticas , Biomarcadores , Brasil , Criança , DNA Viral/análise , Progressão da Doença , Feminino , Infecções por HTLV-I/complicações , Infecções por HTLV-I/patologia , Vírus Linfotrópico T Tipo 1 Humano/genética , Humanos , Leucócitos Mononucleares/patologia , Leucócitos Mononucleares/virologia , Masculino , Pessoa de Meia-Idade , Paraparesia Espástica Tropical/complicações , Paraparesia Espástica Tropical/patologia , Reação em Cadeia da Polimerase , Valor Preditivo dos Testes , Provírus/genética , Doenças da Medula Espinal/complicações , Doenças da Medula Espinal/patologia
2.
Nutrition ; 26(6): 662-70, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20371167

RESUMO

OBJECTIVE: The effect of zinc and glutamine on brain development was investigated during the lactation period in Swiss mice. METHODS: Malnutrition was induced by clustering the litter size from 6-7 pups/dam (nourished control) to 12-14 pups/dam (undernourished control) following birth. Undernourished groups received daily supplementation with glutamine by subcutaneous injections starting at day 2 and continuing until day 14. Glutamine (100 mM, 40-80 microL) was used for morphological and behavioral studies. Zinc acetate was added in the drinking water (500 mg/L) to the lactating dams. Synaptophysin and myelin basic protein brain expressions were evaluated by immunoblot. Zinc serum and brain levels and hippocampal neurotransmitters were also evaluated. RESULTS: Zinc with or without glutamine improved weight gain as compared to untreated, undernourished controls. In addition, zinc supplementation improved cliff avoidance and head position during swim behaviors especially on days 9 and 10. Using design-based stereological methods, we found a significant increase in the volume of CA1 neuronal cells in undernourished control mice, which was not seen in mice receiving zinc or glutamine alone or in combination. Undernourished mice given glutamine showed increased CA1 layer volume as compared with the other groups, consistent with the trend toward increased number of neurons. Brain zinc levels were increased in the nourished and undernourished-glutamine treated mice as compared to the undernourished controls on day 7. Undernourished glutamine-treated mice showed increased hippocampal gamma-aminobutyric acid and synaptophysin levels on day 14. CONCLUSION: We conclude that glutamine or zinc protects against malnutrition-induced brain developmental impairments.


Assuntos
Comportamento Animal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Glutamina/farmacologia , Desnutrição/tratamento farmacológico , Micronutrientes/farmacologia , Aumento de Peso/efeitos dos fármacos , Zinco/farmacologia , Animais , Animais Recém-Nascidos/crescimento & desenvolvimento , Animais Recém-Nascidos/metabolismo , Encéfalo/crescimento & desenvolvimento , Encéfalo/metabolismo , Suplementos Nutricionais , Quimioterapia Combinada , Feminino , Glutamina/uso terapêutico , Lactação , Desnutrição/sangue , Camundongos , Micronutrientes/sangue , Neurônios/efeitos dos fármacos , Gravidez , Natação , Sinaptofisina/metabolismo , Zinco/sangue , Zinco/uso terapêutico , Acetato de Zinco/farmacologia , Ácido gama-Aminobutírico/metabolismo
3.
Neuromuscul Disord ; 19(10): 711-3, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19553119

RESUMO

We report a 52 year-old woman with a past history of lepromatous leprosy (14 years prior to our first evaluation) who presented with progressive weakness and severe arm/leg pain. CSF analysis revealed elevated protein level with normal cell count. Skin and sural nerve biopsy showed no bacilli. Immunomodulatory treatment led to major improvement on clinical, CSF and electrodiagnostic grounds, but after one year of treatment, skin test revealed leprosy relapse. To our knowledge, this is the first report of a multifocal inflammatory neuropathy heralding leprosy relapse. Extended neurological work-up may be important in unexplained neuropathy progression after leprosy treatment.


Assuntos
Hanseníase Virchowiana/fisiopatologia , Debilidade Muscular/fisiopatologia , Doenças do Sistema Nervoso Periférico/fisiopatologia , Progressão da Doença , Feminino , Humanos , Imunoterapia , Hanseníase Virchowiana/líquido cefalorraquidiano , Hanseníase Virchowiana/tratamento farmacológico , Pessoa de Meia-Idade , Debilidade Muscular/líquido cefalorraquidiano , Debilidade Muscular/terapia , Doenças do Sistema Nervoso Periférico/líquido cefalorraquidiano , Doenças do Sistema Nervoso Periférico/terapia , Recidiva , Pele/microbiologia , Pele/patologia , Nervo Sural/microbiologia , Nervo Sural/patologia , Fatores de Tempo , Resultado do Tratamento
4.
Pediatr Res ; 57(2): 310-6, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15611352

RESUMO

Polymorphisms in the apolipoprotein E (APOE) have constituted the major rationale to identify potential risk groups for developing late-onset Alzheimer's disease and help to predict recovery of cognitive function after brain injury. However, the APOE impact on cognitive development in children living in poor areas of the developing world, where we have discovered profound significant associations of early childhood diarrhea (at 0-2 y) with lasting impairments of growth, cognition, and school performance, is not known. Therefore, we conducted APOE genotyping in 72 Brazilian shantytown children under active surveillance since birth, using purified DNA extracted from buccal cell samples. We found a high frequency of APOE4 alleles (18% versus 9-11% expected) in children with lower diarrhea burdens. When we examined the children who experienced the heavier diarrhea burdens (greater than or equal to the median of seven illnesses in the first 2 y of life), those with APOE4 did significantly better in the coding subtest (p=0.01) when compared with APOE4-negative children with similar diarrhea burdens. Positive correlations between the APOE4 occurrence and coding scores remained, even after adjusting for family income, maternal education, and breast-feeding. Moreover, the APOE4-positive group, under heavy burdens of diarrhea, had preserved semantic fluency and the mean difference in fluency scores, p=0.025, a standardized coefficient for disproportional verbal fluency impairment. Our findings show that APOE4 is relatively common in favela children and suggest a protective role of the APOE4 allele in children with a history of heavy burdens of diarrhea in their first 2 y of life.


Assuntos
Apolipoproteínas E/fisiologia , Diarreia/complicações , Alelos , Apolipoproteína E4 , Apolipoproteínas E/metabolismo , Brasil , Cognição , Estudos de Coortes , DNA/metabolismo , Feminino , Frequência do Gene , Genótipo , Humanos , Lactente , Recém-Nascido , Masculino , Polimorfismo Genético , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...